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Letters to the Editor2 published cases1,3 with air embolism
have something in common: an S8
segmentectomy. At present, we have
no idea what this means. Is the
anatomy of the vascular structures
a risk factor?
We also considered air embolism,
and our article,2 which stated, ‘‘Poten-
tial pitfalls include anomalous bron-
chial anatomy and air embolism if
the pulmonary artery branch is inad-
vertently punctured,’’ warned of this.
We have performed anatomic segmen-
tectomies in 53 patients as of Septem-
ber 2011 and have never experienced
an air embolism.4 We might have just
been lucky. However, we take the fol-
lowing steps to avoid air embolism:
 The targeted vessels are divided
first.
 When we are certain that the tar-
geted bronchus has been identified,
we always divide the bronchus first,
hoist the bronchial stump with
a string or forceps, and then try to
insert the needle into the bronchial
stump in the direction of the long
axis of the bronchus.
 We always use 100% oxygen gas
and a 23-gauge butterfly needle,
which is a relatively thin needle.
 The instillation of oxygen into the
bronchus is limited to 0.5 to 1.5 L,
and the oxygen flow rate is no
greater than needed, which prevents
excessive air flow into the pulmo-
nary parenchyma.
 If vessel puncture is of particular
concern, a thin catheter with a bal-
loon is used instead of a butterfly
needle.
Wewould like to ask Otsuka and as-
sociates the following questions:
 What is the direction of puncture of
the targeted bronchus?
 What flow rate or air pressure is
used?
 Why do you use an 18-gauge nee-
dle; is the stump too thick for inser-
tion of a B8?
 Although it was confirmed that
there was no blood regurgitation,
was air reflux confirmed?The Journal It is odd that air was not confirmed
in the target area after the air was
blown into the tube. We postulate
that the needle was inserted into
the pulmonary parenchyma. If air
were to be instilled into the pulmo-
nary parenchyma, an air embolism
would not be unusual, as seen with
the computed tomography–guided
marking technique.5
Would you please comment on the
last point and elaborate on our
questions?
Nomatter how careful we are, prob-
lems can occur, and this may serve to
heighten our caution. Finally, we
thank Otsuka and associates for pro-
viding important information on the
pros and cons of the selected segmen-
tal inflation technique.
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We thank Kamiyoshihara, Naga-
shima, and Igai for their comments
on our article1 and are pleased to
reply.
Pulmonary segmentectomy with
video-assisted thoracic surgery proce-
dures has been one of the common
methods for lung cancer as smaller tu-
mors have begun to be identified. The
selected segmental inflation technique
is frequently used in Japan for detect-
ing the intersegmental plane.2,3 We
also used the technique with an 18-
gauge needle, as we mentioned.1 We
punctured the bronchus longitudinally
just as Kamiyoshihara, Kakegawa,
and Morishita2 described. To puncture
a bronchus, we use a relatively thick
needle, which is less resistant while
air is being blown. The punctured
stump of the B8 on this occasion was
more than 5 mm across. There was
no thickening of the bronchial wall,
which we did not find difficult to
puncture. We used air, not oxygen, to
inflate the selected segment to avoid
explosion. Air was blown at a pressure
of 0.1 MPa by using a regulator. No
blood regurgitation was confirmed un-
der atmospheric pressure when the in-
ner needle was removed after the
syringe needle punctured the bron-
chus. Inasmuch as negative pressure
was not applied by using a syringe,
air regurgitation was not confirmed.
As Kamiyoshihara, Nagashima,
and Igai, pointed out, it is odd that
air was not confirmed in the target
area after the air was blown into the
tube. We would like to suggest 2 pos-
sible reasons for this. First, as the au-
thors suggested, air blown into the
lung parenchyma via the tip of the
needle caused air embolism at the
end. The other possible reason is that
the tip of the needle moved accidently
into the vein, which allowed air to be
blown directly into it, causing air em-
bolism. It is hard to ascertain which
mechanism caused the complication
this time. There would be less risk of
air embolism if we adopted the tech-
nique that Kamiyoshihara has used.ry c Volume 143, Number 4 991
Letters to the EditorHowever, so long as the needle
method is used, there is always a po-
tential risk of air embolism caused
by the tip of a needle moving acci-
dently. We recommend an ‘‘open-cut’’
selected segmental inflation technique
without use of a needle or the selected
segmental inflation technique through
a thin bronchoscope.3
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RADIOFREQUENCYABLATION
FOR PATIENTS WITH
NONDYSPLASTIC BARRETT’S
ESOPHAGUS
To the Editor:
In his recent commentary article
entitled ‘‘Radiofrequency ablation
for nondysplastic Barrett’s esophagus:
Should we do it, because we can?’’
Veeramachaneni1 summarizes his per-
spective with the statement that ‘‘In
light of the ambiguity of the natural
history of Barrett’s esophagus without
dysplasia, radiofrequency ablation
should currently only be done in the
context of a clinical trial.’’ Although
we do agree that the routine use of ra-
diofrequency ablation for patients992 The Journal of Thoracic and Cwith nondysplastic Barrett’s esopha-
gus (BE) should not be considered
the standard of care, we also believe
that several considerations need to be
taken into account before such a blan-
ket statement can be made.
First, as Veeramachaneni1 correctly
points out, the current recommenda-
tion for nondysplastic BE consists
of surveillance endoscopy with sys-
tematic biopsy. Even so, it is well
documented that the majority of phy-
sicians in the United States and abroad
do not follow the recommendations,
especially relating to the number and
systematic nature of the biopsy sam-
ples needed.2
Second, a significant number (as
many as half) of patients with BE
who have had either high-grade dys-
plasia or invasive cancer did not
have dysplasia detected during their
previous endoscopies.3
Third, all patients with nondysplas-
tic BE are probably not the same with
regard to their cancer risk. For exam-
ple, patients with longer segments of
BE appear to be at a higher risk of de-
velopment of invasive cancer.4 In ad-
dition, younger patients with BE
may also be at a higher risk of even-
tual development of invasive cancer,
as extrapolated from evidence that
indicates that the duration of BE is
a determinate of cancer risk4 com-
bined with recent population-based
data that suggest that the annual risk
of development of invasive cancer
persists with time.5
Fourth, radiofrequency ablation for
BE is a very safe procedure, and it
is associated with an extremely low
complication rate.6 Indeed, among
the 179 ablation procedures perfor-
med in our own phase II clinical trial
(both dysplastic and nondysplastic
BE), adverse events occurred after
only 13 procedures (7%), and all
complications were minor: fever
(n¼ 5), inability to line up the circum-
ferential ablation device effectively
(n ¼ 3), self-limited bleeding (n ¼
1), asymptomatic and spontaneously
resolving stricture (n ¼ 1), aspirationardiovascular Surgery c April 2012(n ¼ 1), transient heart block (n ¼
1), and esophageal candidiasis
(n ¼ 1).
Finally, radiofrequency ablation re-
sults in eradication of BE in the ma-
jority of cases in which it is used.6
Further, data from a randomized,
sham-controlled trial indicate that
cancer risk is reduced by the use of
radiofrequency ablation in patients
with dysplastic BE.6 Whether this
cancer prevention effect persists for
nondysplastic BE is unknown and
would require a much larger random-
ized trial to address.
In summary, although we agree
that radiofrequency ablation should
not currently be used routinely for
nondysplastic lesions, we are fortu-
nate enough to have access to a very
safe, effective technology for eradi-
cating BE. Given this fact, along
with the variable malignant potential
of nondysplastic BE, the ‘‘ambiguity’’
associated with nondysplastic BE that
Veeramachaneni describes in his com-
mentary, and the inconsistencies in-
herent in the practice of surveillance,
we believe that the universal exclusion
of patients with nondysplastic lesions
from access to radiofrequency abla-
tion is a mistake.
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